Aina Hirofuji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aina Hirofuji has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Hiroyuki Kamiya
Department of Cardiac Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka, Higashi, Asahikawa, Hokkaido, Japan
12 shared publications- Ryohei Ushioda
Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan
10 shared publications - Ryo Okubo
Department of Cardiac Surgery, Asahikawa Medical University , Midorigaoka Higashi 2-1-1-1, Asahikawa 078-8510
9 shared publications - Shingo Kunioka
Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
9 shared publications - Hiroyuki Kamiya
Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
6 shared publications Akito Inoue
Department of Cardiac Surgery, Asahikawa Medical University , Midorigaoka 1-1-1, Asahikawa, Hokkaido 078-8510
4 shared publications
Latest Publications
- Open Access
- 22 April 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 820, 153765
Kdm4dl is expressed in adult mouse testis and encodes a functional KDM4D-like protein
- 22 April 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 820, 153765
Open AccessKdm4dl is expressed in adult mouse testis and encodes a functional KDM4D-like protein
- Open Access
- 21 April 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (8) , e046146
Mycn Reactivates the Cell Cycle in Adult Cardiomyocytes and Promotes Cardioprotection in Myocardial Infarction
Background: Adult cardiomyocytes are terminally differentiated with limited capacity for cell cycle re‐entry. However, recent studies have shown that cycling cardiomyocytes may exert cardioprotective effects after myocardial infarction (MI). The Myc family— Myc , Mycl , and Mycn —regulates cell cycle progression and plasticity, raising the possibility that specific isoforms could reactivate cardiomyocyte cycling and therefore enhance cardiac repair in MI. This study evaluated the effects of Myc isoforms on cardiomyocyte cell cycle activation and cardiac outcomes after MI. Methods: Cardiomyocyte‐specific overexpression of Myc , Mycl , or Mycn was induced in adult mice using adeno‐associated virus 9 vectors driven by the cardiac troponin T promoter. Cell cycle activity, remodeling, and function were assessed by RNA sequencing, immunohistochemistry, and echocardiography. Cardioprotection was evaluated in MI models. Results: Mycn elicited the most robust cell cycle gene expression among the Myc isoforms. Mycn overexpression markedly enhanced cardiomyocyte re‐entry—evidenced by increased 5‐bromo‐2′‐deoxyuridine incorporation and histone H3 phosphorylation—and induced hypertrophic growth. Transcriptomic profiling revealed Mycn ‐specific upregulation of extracellular matrix and paracrine signaling genes, which are typically enriched in neonatal cardiomyocytes and also linked to cardioprotection. In MI models, Mycn preserved cardiac contractility, reduced infarct size, and increased capillary density in peri‐infarct regions. Conclusions: Mycn exerts robust biological effects in the adult heart, including reactivation of the cardiomyocyte cell cycle and promotion of cardioprotection following ischemic injury. Its effects likely involve induction of a neonatal‐like transcriptional program that fosters a stress‐adaptive microenvironment.
- 21 April 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (8) , e046146
Open AccessMycn Reactivates the Cell Cycle in Adult Cardiomyocytes and Promotes Cardioprotection in Myocardial Infarction
Background: Adult cardiomyocytes are terminally differentiated with limited capacity for cell cycle re‐entry. However, recent studies have shown that cycling cardiomyocytes may exert cardioprotective effects after myocardial infarction (MI). The Myc family— Myc , Mycl , and Mycn —regulates cell cycle progression and plasticity, raising the possibility that specific isoforms could reactivate cardiomyocyte cycling and therefore enhance cardiac repair in MI. This study evaluated the effects of Myc isoforms on cardiomyocyte cell cycle activation and cardiac outcomes after MI. Methods: Cardiomyocyte‐specific overexpression of Myc , Mycl , or Mycn was induced in adult mice using adeno‐associated virus 9 vectors driven by the cardiac troponin T promoter. Cell cycle activity, remodeling, and function were assessed by RNA sequencing, immunohistochemistry, and echocardiography. Cardioprotection was evaluated in MI models. Results: Mycn elicited the most robust cell cycle gene expression among the Myc isoforms. Mycn overexpression markedly enhanced cardiomyocyte re‐entry—evidenced by increased 5‐bromo‐2′‐deoxyuridine incorporation and histone H3 phosphorylation—and induced hypertrophic growth. Transcriptomic profiling revealed Mycn ‐specific upregulation of extracellular matrix and paracrine signaling genes, which are typically enriched in neonatal cardiomyocytes and also linked to cardioprotection. In MI models, Mycn preserved cardiac contractility, reduced infarct size, and increased capillary density in peri‐infarct regions. Conclusions: Mycn exerts robust biological effects in the adult heart, including reactivation of the cardiomyocyte cell cycle and promotion of cardioprotection following ischemic injury. Its effects likely involve induction of a neonatal‐like transcriptional program that fosters a stress‐adaptive microenvironment.
- Open Access
- 24 December 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (1)
Bentall procedure for giant unruptured right sinus of Valsalva aneurysm treated
A sinus of Valsalva aneurysm (SVA) is a rare cardiac anomaly that may remain silent until rupture, often leading to acute heart failure. Surgical intervention is advised for unruptured SVAs when large, progressive, or associated with aortic regurgitation (AR). We report a 72-year-old woman with a 25-mm right coronary SVA and severe symptomatic AR. Transthoracic echocardiography confirmed severe AR with preserved ventricular function. A Bentall procedure using a bioprosthetic valve and Valsalva graft was performed, with coronary button reimplantation with the Carrel patch technique. The postoperative course was uneventful, and the patient remained free of recurrence at 2-year follow-up. This case highlights the Bentall procedure as a durable option for unruptured SVA with root distortion and valve involvement, offering reliable prevention of late AR and reintervention.
- 24 December 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (1)
Open AccessBentall procedure for giant unruptured right sinus of Valsalva aneurysm treated
A sinus of Valsalva aneurysm (SVA) is a rare cardiac anomaly that may remain silent until rupture, often leading to acute heart failure. Surgical intervention is advised for unruptured SVAs when large, progressive, or associated with aortic regurgitation (AR). We report a 72-year-old woman with a 25-mm right coronary SVA and severe symptomatic AR. Transthoracic echocardiography confirmed severe AR with preserved ventricular function. A Bentall procedure using a bioprosthetic valve and Valsalva graft was performed, with coronary button reimplantation with the Carrel patch technique. The postoperative course was uneventful, and the patient remained free of recurrence at 2-year follow-up. This case highlights the Bentall procedure as a durable option for unruptured SVA with root distortion and valve involvement, offering reliable prevention of late AR and reintervention.
- Open Access
- 24 December 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (1)
Total venous coronary artery bypass grafting for acute myocardial infarction with Leriche syndrome and porcelain aorta: a case report
Leriche syndrome is an occlusive disease involving the abdominal aorta and iliac arteries that is frequently associated with ischemic heart disease (IHD). The internal thoracic arteries in patients with Leriche syndrome often serve as important collateral pathways to the lower extremities. Therefore, graft selection for coronary artery bypass grafting (CABG) requires special consideration. We performed on-pump total venous CABG in a patient with acute heart failure secondary to IHD complicated by Leriche syndrome who required emergent coronary revascularization. This strategy was chosen to preserve lower limb perfusion. When coronary revascularization is a priority for patients with IHD complicated by Leriche syndrome, on-pump total venous CABG is a reasonable option because of the need to preserve lower limb perfusion and difficulty of using mechanical circulatory support devices for occlusive disease.
- 24 December 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (1)
Open AccessTotal venous coronary artery bypass grafting for acute myocardial infarction with Leriche syndrome and porcelain aorta: a case report
Leriche syndrome is an occlusive disease involving the abdominal aorta and iliac arteries that is frequently associated with ischemic heart disease (IHD). The internal thoracic arteries in patients with Leriche syndrome often serve as important collateral pathways to the lower extremities. Therefore, graft selection for coronary artery bypass grafting (CABG) requires special consideration. We performed on-pump total venous CABG in a patient with acute heart failure secondary to IHD complicated by Leriche syndrome who required emergent coronary revascularization. This strategy was chosen to preserve lower limb perfusion. When coronary revascularization is a priority for patients with IHD complicated by Leriche syndrome, on-pump total venous CABG is a reasonable option because of the need to preserve lower limb perfusion and difficulty of using mechanical circulatory support devices for occlusive disease.
- Open Access
- 24 December 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (1) , rjaf1025
Successful double valve replacement with extensive annular enlargement using the Commando procedure in a patient with small aortic and mitral annuli after previous double valve surgery
We report a 70-year-old woman (body surface area 1.42 m2) undergoing redo double valve replacement with extensive annular enlargement using the Commando procedure. Thirteen years earlier, she received aortic valve replacement (St. Jude Medical 19 mm), mitral repair (Physio Ring 24 mm), and tricuspid annuloplasty. She presented with progressive heart failure; echocardiography showed severe mitral stenosis (mitral valve area 0.96 cm2) and moderate aortic stenosis with moderate paravalvular leak. To avert patient–prosthesis mismatch (PPM), both annuli were enlarged with bovine pericardium, permitting implantation of an Epic 27 mm mitral and an Inspiris 23 mm aortic bioprosthesis. Postoperative echocardiography demonstrated excellent hemodynamics (aortic effective orifice area 1.76 cm2, mean gradient 6 mmHg; mitral mean gradient 3 mmHg). Recovery was uneventful, and she remains asymptomatic. Commando surgery enabled safe, simultaneous enlargement of both annuli, minimizing PPM, and preserving options for future valve-in-valve therapy.
- 24 December 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (1) , rjaf1025
Open AccessSuccessful double valve replacement with extensive annular enlargement using the Commando procedure in a patient with small aortic and mitral annuli after previous double valve surgery
We report a 70-year-old woman (body surface area 1.42 m2) undergoing redo double valve replacement with extensive annular enlargement using the Commando procedure. Thirteen years earlier, she received aortic valve replacement (St. Jude Medical 19 mm), mitral repair (Physio Ring 24 mm), and tricuspid annuloplasty. She presented with progressive heart failure; echocardiography showed severe mitral stenosis (mitral valve area 0.96 cm2) and moderate aortic stenosis with moderate paravalvular leak. To avert patient–prosthesis mismatch (PPM), both annuli were enlarged with bovine pericardium, permitting implantation of an Epic 27 mm mitral and an Inspiris 23 mm aortic bioprosthesis. Postoperative echocardiography demonstrated excellent hemodynamics (aortic effective orifice area 1.76 cm2, mean gradient 6 mmHg; mitral mean gradient 3 mmHg). Recovery was uneventful, and she remains asymptomatic. Commando surgery enabled safe, simultaneous enlargement of both annuli, minimizing PPM, and preserving options for future valve-in-valve therapy.
- Open Access
- 2 November 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (11)
Early structural valve deterioration of a pulmonary position Inspiris Resilia valve requiring redo pulmonary and tricuspid valve replacement
We report a 50-year-old woman with pulmonary and tricuspid valve regurgitation who required redo pulmonary and tricuspid valve replacement (PVR, TVR). At age 8, she underwent right ventricular outflow tract reconstruction for pulmonary stenosis, and at 44 years she had PVR with a 19 mm Inspiris Resilia bioprosthesis and tricuspid annuloplasty with a 28 mm Physio ring. Three years later, she presented with palpitations and syncope. Echocardiography revealed severe tricuspid regurgitation and moderate pulmonary regurgitation due to dysfunction of a prosthetic leaflet. Redo PVR with a 29 mm Inspiris Resilia valve and TVR with a 27 mm Mitris valve was performed. Early structural valve deterioration of the initial Inspiris prosthesis was suspected. Our experience suggests that using a larger prosthesis may mitigate early degeneration and preserve the option of future transcatheter PVR.
- 2 November 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (11)
Open AccessEarly structural valve deterioration of a pulmonary position Inspiris Resilia valve requiring redo pulmonary and tricuspid valve replacement
We report a 50-year-old woman with pulmonary and tricuspid valve regurgitation who required redo pulmonary and tricuspid valve replacement (PVR, TVR). At age 8, she underwent right ventricular outflow tract reconstruction for pulmonary stenosis, and at 44 years she had PVR with a 19 mm Inspiris Resilia bioprosthesis and tricuspid annuloplasty with a 28 mm Physio ring. Three years later, she presented with palpitations and syncope. Echocardiography revealed severe tricuspid regurgitation and moderate pulmonary regurgitation due to dysfunction of a prosthetic leaflet. Redo PVR with a 29 mm Inspiris Resilia valve and TVR with a 27 mm Mitris valve was performed. Early structural valve deterioration of the initial Inspiris prosthesis was suspected. Our experience suggests that using a larger prosthesis may mitigate early degeneration and preserve the option of future transcatheter PVR.
- Open Access
Mycn Reactivates the Cell Cycle in Adult Cardiomyocytes and Promotes Cardioprotection in Myocardial Infarction
Background: Adult mammalian cardiomyocytes are terminally differentiated and possess minimal capacity for cell cycle re-entry. However, recent studies have shown that a rare population of cycling cardiomyocytes may confer cardioprotective effects following myocardial infarction (MI). The Myc family—Myc, Mycl, and Mycn—plays central roles in regulating cell cycle progression and cellular plasticity. This raises the possibility that specific Myc isoforms could reactivate the cardiomyocyte cell cycle and promote cardioprotective responses in the ischemic heart. This study aimed to systematically evaluate the effects of Myc, Mycl, and Mycn on cardiomyocyte cell cycle activation and cardiac outcomes following MI. Methods: Cardiomyocyte-specific overexpression of Myc , Mycl , or Mycn was achieved in adult mice via adeno-associated virus 9 vectors driven by the cardiac troponin T promoter. Cardiomyocyte cell cycle activity, structural remodeling, and functional outcomes were assessed using RNA sequencing, immunohistochemistry, and transthoracic echocardiography. Cardioprotective effects were evaluated in MI model mice. Results: While all three Myc family members activated cell cycle-related gene expression to varying degrees, Mycn elicited the most robust response. Mycn overexpression significantly enhanced cardiomyocyte cell cycle re-entry, as demonstrated by increased 5-bromo-2’-deoxyuridine incorporation and phosphorylation of histone H3. Mycn also induced hypertrophic growth, reflected by increased cardiomyocyte size and heart mass. Transcriptomic analyses revealed that Mycn uniquely upregulated genes associated with extracellular matrix remodeling and paracrine signaling, typically enriched in neonatal cardiomyocytes and previously linked to cardioprotection. Functionally, Mycn expression preserved cardiac contractility after MI, reduced infarct size, and increased capillary density in peri-infarct regions. Conclusions: These findings identify Mycn as a functionally distinct member of the Myc family in the adult heart, capable of reactivating the cardiomyocyte cell cycle and promoting cardiac protection after ischemic injury. The cardioprotective effects appear to be mediated, in part, by the induction of a neonatal-like gene expression program supporting a stress-adaptive cardiac microenvironment.
Open AccessMycn Reactivates the Cell Cycle in Adult Cardiomyocytes and Promotes Cardioprotection in Myocardial Infarction
Background: Adult mammalian cardiomyocytes are terminally differentiated and possess minimal capacity for cell cycle re-entry. However, recent studies have shown that a rare population of cycling cardiomyocytes may confer cardioprotective effects following myocardial infarction (MI). The Myc family—Myc, Mycl, and Mycn—plays central roles in regulating cell cycle progression and cellular plasticity. This raises the possibility that specific Myc isoforms could reactivate the cardiomyocyte cell cycle and promote cardioprotective responses in the ischemic heart. This study aimed to systematically evaluate the effects of Myc, Mycl, and Mycn on cardiomyocyte cell cycle activation and cardiac outcomes following MI. Methods: Cardiomyocyte-specific overexpression of Myc , Mycl , or Mycn was achieved in adult mice via adeno-associated virus 9 vectors driven by the cardiac troponin T promoter. Cardiomyocyte cell cycle activity, structural remodeling, and functional outcomes were assessed using RNA sequencing, immunohistochemistry, and transthoracic echocardiography. Cardioprotective effects were evaluated in MI model mice. Results: While all three Myc family members activated cell cycle-related gene expression to varying degrees, Mycn elicited the most robust response. Mycn overexpression significantly enhanced cardiomyocyte cell cycle re-entry, as demonstrated by increased 5-bromo-2’-deoxyuridine incorporation and phosphorylation of histone H3. Mycn also induced hypertrophic growth, reflected by increased cardiomyocyte size and heart mass. Transcriptomic analyses revealed that Mycn uniquely upregulated genes associated with extracellular matrix remodeling and paracrine signaling, typically enriched in neonatal cardiomyocytes and previously linked to cardioprotection. Functionally, Mycn expression preserved cardiac contractility after MI, reduced infarct size, and increased capillary density in peri-infarct regions. Conclusions: These findings identify Mycn as a functionally distinct member of the Myc family in the adult heart, capable of reactivating the cardiomyocyte cell cycle and promoting cardiac protection after ischemic injury. The cardioprotective effects appear to be mediated, in part, by the induction of a neonatal-like gene expression program supporting a stress-adaptive cardiac microenvironment.
- Open Access
- 21 August 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1397396
The left axillary artery is a reasonable option as the inflow site for saphenous vein graft in minimally invasive coronary artery bypass grafting
Introduction: This study aims to clarify the good inflow site for saphenous vein grafts (SVG) in minimally invasive off-pump coronary artery bypass grafting (mini-CABG), between the ascending aorta, the internal thoracic arteries (ITAs) and the left axillary artery (LAA).Methods: This retrospective study included 126 patients who underwent Mini-CABG at our center between January 2014 and July 2023. Patients were divided into three groups according to the SVG inflow site for patency comparison: Aorta group (n = 56), LAA group (n = 23), and ITA group (n = 47).Results: There were 84 males, with mean age of 65.9 ± 7.0 years. There were no significant differences in preoperative characteristics between groups. Mean operation times were 254.6 ± 72.2, 213.7 ± 57.6, and 253.0 ± 81.2 min, and the average numbers of distal anastomoses were 2.9 ± 0.9, 2.4 ± 0.7 and 2.9 ± 1.1 in the Aorta, ITA and LAA groups respectively. Days in intensive care, hospital stay, and major complications did not differ between the groups. Early patency of SVG did not significantly differ among groups: 93.0% in the Aorta group, 98.0% in the ITA group, and 100% in the LAA group. Mean follow-up period was 136.7 ± 295.7 days, and follow-up coronary CTA revealed 18 SVG occlusions (Aorta group n = 8, ITA group n = 5, LAA group n = 5). The Kaplan-Meier curve for SVG patency rates did not show any significant differences among the three groups.Conclusion: The ascending aorta, the ITAs, and the LAA serve as reliable inflow sites with similar results in mini-CABG.
- 21 August 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1397396
Open AccessThe left axillary artery is a reasonable option as the inflow site for saphenous vein graft in minimally invasive coronary artery bypass grafting
Introduction: This study aims to clarify the good inflow site for saphenous vein grafts (SVG) in minimally invasive off-pump coronary artery bypass grafting (mini-CABG), between the ascending aorta, the internal thoracic arteries (ITAs) and the left axillary artery (LAA).Methods: This retrospective study included 126 patients who underwent Mini-CABG at our center between January 2014 and July 2023. Patients were divided into three groups according to the SVG inflow site for patency comparison: Aorta group (n = 56), LAA group (n = 23), and ITA group (n = 47).Results: There were 84 males, with mean age of 65.9 ± 7.0 years. There were no significant differences in preoperative characteristics between groups. Mean operation times were 254.6 ± 72.2, 213.7 ± 57.6, and 253.0 ± 81.2 min, and the average numbers of distal anastomoses were 2.9 ± 0.9, 2.4 ± 0.7 and 2.9 ± 1.1 in the Aorta, ITA and LAA groups respectively. Days in intensive care, hospital stay, and major complications did not differ between the groups. Early patency of SVG did not significantly differ among groups: 93.0% in the Aorta group, 98.0% in the ITA group, and 100% in the LAA group. Mean follow-up period was 136.7 ± 295.7 days, and follow-up coronary CTA revealed 18 SVG occlusions (Aorta group n = 8, ITA group n = 5, LAA group n = 5). The Kaplan-Meier curve for SVG patency rates did not show any significant differences among the three groups.Conclusion: The ascending aorta, the ITAs, and the LAA serve as reliable inflow sites with similar results in mini-CABG.
- Open Access
- 7 May 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1393921
Assessing the benefits of anaortic off-pump coronary artery bypass grafting
Introduction: The procedure called the “aorta no-touch” (NT) or anaortic technique in off-pump coronary artery bypass grafting (OPCAB) is designed to reduce the perioperative risk of stroke. We have observed an increased frequency of anaortic OPCAB procedures at our institution. The main purpose of the present study is to investigate the effectiveness of anaortic OPCAB in reducing the perioperative risk of stroke.Methods: From April 2011 to July 2023, a total of 2,236 patients underwent isolated OPCAB at our single center. The patients were divided into the anaortic group (NT, n = 762) and the aortic group (A, n = 1,474). The NT group was propensity score-matched (PSM) with the A group at a 1:1 ratio (NT n = 640; A n = 640), and matching was performed based on 26 covariates with preoperative clinical characteristics.Results: In both the unmatched and matched cohorts of the NT and A groups, there were no significant differences observed in new stroke rates (NT vs. A; unmatched, 1.0% vs. 1.2%, p = 0.624; matched, 0.9% vs. 1.3%, p = 0.789). The univariable logistic analysis did not identify the anaortic technique as an independent factor negatively associated with new stroke events (OR = 0.81, 95% CI = 0.35–1.86, p = 0.624).Conclusion: The present study did not find the anaortic technique to reduce the perioperative risk of stroke in OPCAB. Hence, further large studies are needed to identify patient cohorts in which anaortic OPCAB is significantly beneficial.
- 7 May 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1393921
Open AccessAssessing the benefits of anaortic off-pump coronary artery bypass grafting
Introduction: The procedure called the “aorta no-touch” (NT) or anaortic technique in off-pump coronary artery bypass grafting (OPCAB) is designed to reduce the perioperative risk of stroke. We have observed an increased frequency of anaortic OPCAB procedures at our institution. The main purpose of the present study is to investigate the effectiveness of anaortic OPCAB in reducing the perioperative risk of stroke.Methods: From April 2011 to July 2023, a total of 2,236 patients underwent isolated OPCAB at our single center. The patients were divided into the anaortic group (NT, n = 762) and the aortic group (A, n = 1,474). The NT group was propensity score-matched (PSM) with the A group at a 1:1 ratio (NT n = 640; A n = 640), and matching was performed based on 26 covariates with preoperative clinical characteristics.Results: In both the unmatched and matched cohorts of the NT and A groups, there were no significant differences observed in new stroke rates (NT vs. A; unmatched, 1.0% vs. 1.2%, p = 0.624; matched, 0.9% vs. 1.3%, p = 0.789). The univariable logistic analysis did not identify the anaortic technique as an independent factor negatively associated with new stroke events (OR = 0.81, 95% CI = 0.35–1.86, p = 0.624).Conclusion: The present study did not find the anaortic technique to reduce the perioperative risk of stroke in OPCAB. Hence, further large studies are needed to identify patient cohorts in which anaortic OPCAB is significantly beneficial.
- Open Access
- 7 May 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1391881
Multi-vessel coronary artery grafting: analyzing the minimally invasive approach and its safety
Introduction: At our institution, we perform off-pump coronary artery bypass (OPCAB) as a standard procedure. Moreover, patients with favorable coronary anatomy and condition are selected for minimally invasive cardiac surgery (MICS)-OPCAB. We retrospectively compared early outcomes, focusing on safety, between MICS-OPCAB and conventional off-pump techniques for multivessel coronary artery bypass grafting (CABG).Methods: From August 2017 to September 2022, 1,220 patients underwent multivessel coronary artery grafting at our institution. They were divided into the MICS-OPCAB group (MICS group = 163 patients) and the conventional OPCAB group (MS group = 1057 patients). Propensity score matching (1 : 1 ratio) was applied to the MICS-OPCAB and MS groups (149 patients per group) based on 23 preoperative clinical characteristics.Results: After matching, there were no significant differences in preoperative characteristics between the groups. The MICS group had a lower total graft number (2.3 ± 0.6 vs. 2.9 ± 0.8, p < 0.001) and fewer distal anastomoses (2.7 ± 0.8 vs. 3.2 ± 0.9, p < 0.001). There were no significant differences in hospital stay, intensive care unit stay, postoperative complications, and 30-day mortality. The MICS group had less drain output (MICS 350 ml [250–500], MS 450 ml [300–550]; p = 0.013). Kaplan–Meier analysis revealed no significant differences in postoperative MACCE (major adverse cardiac or cerebrovascular events)-free and survival rates between the groups (MACCE-free rate p = 0.945, survival rate p = 0.374).Conclusion: With proper patient selection, MICS-OPCAB can provide good short to mid-term results, similar to those of conventional OPCAB.
- 7 May 2024
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1391881
Open AccessMulti-vessel coronary artery grafting: analyzing the minimally invasive approach and its safety
Introduction: At our institution, we perform off-pump coronary artery bypass (OPCAB) as a standard procedure. Moreover, patients with favorable coronary anatomy and condition are selected for minimally invasive cardiac surgery (MICS)-OPCAB. We retrospectively compared early outcomes, focusing on safety, between MICS-OPCAB and conventional off-pump techniques for multivessel coronary artery bypass grafting (CABG).Methods: From August 2017 to September 2022, 1,220 patients underwent multivessel coronary artery grafting at our institution. They were divided into the MICS-OPCAB group (MICS group = 163 patients) and the conventional OPCAB group (MS group = 1057 patients). Propensity score matching (1 : 1 ratio) was applied to the MICS-OPCAB and MS groups (149 patients per group) based on 23 preoperative clinical characteristics.Results: After matching, there were no significant differences in preoperative characteristics between the groups. The MICS group had a lower total graft number (2.3 ± 0.6 vs. 2.9 ± 0.8, p < 0.001) and fewer distal anastomoses (2.7 ± 0.8 vs. 3.2 ± 0.9, p < 0.001). There were no significant differences in hospital stay, intensive care unit stay, postoperative complications, and 30-day mortality. The MICS group had less drain output (MICS 350 ml [250–500], MS 450 ml [300–550]; p = 0.013). Kaplan–Meier analysis revealed no significant differences in postoperative MACCE (major adverse cardiac or cerebrovascular events)-free and survival rates between the groups (MACCE-free rate p = 0.945, survival rate p = 0.374).Conclusion: With proper patient selection, MICS-OPCAB can provide good short to mid-term results, similar to those of conventional OPCAB.